UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung

PloS one, 2013-11, Vol.8 (11), p.e80292-e80292

2013

Volltextzugriff (PDF)

A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma

Gynecologic oncology, 2014-09, Vol.134 (3), p.478-485

2014

Volltextzugriff (PDF)

357 TAK-573, an anti-CD38–attenuated interferon alpha (IFNα) fusion protein (Attenukine™), has demonstrated IFNα receptor (IFNAR) pathway modulation in patients with relapsed/refractory multiple myeloma

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A382-A382

2020

Volltextzugriff (PDF)

Molecular analysis of circulating tumor DNA (ctDNA) in patients (pts) with EGFR exon 20 insertion-positive (ex20ins+) advanced NSCLC treated with mobocertinib

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9108-9108

2022

Volltextzugriff (PDF)

Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B

Journal of hepatology, 2018-03, Vol.68 (3), p.431-440

2018

Volltextzugriff (PDF)

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

Gastroenterology (New York, N.Y. 1943), 2019-07, Vol.157 (1), p.227-241.e7

2019

Volltextzugriff (PDF)

Statistical design for a confirmatory trial with a continuous predictive biomarker: A case study

Contemporary clinical trials, 2017-12, Vol.63, p.19-29

2017

Volltextzugriff (PDF)

Modakafusp Alfa Demonstrates Type I Interferon-Mediated Innate and Adaptive Immune Enhancement in a Phase 1/2 Study in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Blood, 2023-11, Vol.142 (Supplement 1), p.3316-3316

2023

Volltextzugriff (PDF)

Role of Cell Therapy Product Characteristics in Patient Response to TAK-940 (CD19(T2)28z1xx Chimeric Antigen Receptor (CAR) T): Biomarker Analyses from a Phase I Study in Adult Patients with Relapsed or Refractory B-Cell Malignancies

Blood, 2023-11, Vol.142 (Supplement 1), p.349-349

2023

Volltextzugriff (PDF)

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL

Blood, 2016-05, Vol.127 (20), p.2411-2415

2016

Volltextzugriff (PDF)

A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer

Clinical cancer research, 2013-12, Vol.19 (23), p.6614-6623

2013

Volltextzugriff (PDF)

Abstract 2781: De novo molecular mechanisms of resistance to mobocertinib

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2781-2781

2022

Volltextzugriff (PDF)

Abstract A024: Genomic peroxisome proliferator-activated receptor gamma (PPARG) study: A sponsored testing program to identify patients harboring genetic alterations in advanced UC in support of the FX-909 Phase 1 study

Clinical cancer research, 2024-05, Vol.30 (10_Supplement), p.A024-A024

2024

Volltextzugriff (PDF)

Abstract CT065: Modakafusp alfa shows intratumoral immune pharmacodynamics (PD) in a subset of patients (pts) in a phase 1b study in advanced/metastatic solid tumors

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT065-CT065

2024

Volltextzugriff (PDF)

A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer

European journal of cancer (1990), 2015-09, Vol.51 (13), p.1714-1724

2015

Volltextzugriff (PDF)

A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2014-10, Vol.9 (10), p.1532-1539

2014

Volltextzugriff (PDF)

Safety, Pharmacokinetics and Pharmacodynamics of Selgantolimod, an Oral Toll-Like Receptor 8 Agonist: A Phase Ia Study in Healthy Subjects

Antiviral therapy, 2020-01, Vol.25 (3), p.171-180

2020

Volltextzugriff (PDF)

A phase 2, single‐arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy

Cancer, 2014-06, Vol.120 (11), p.1647-1655

2014

Volltextzugriff (PDF)

Circulating Cytokines and Markers of Iron Metabolism in Myelofibrosis Patients Treated with Momelotininb: Correlatives from the Ym-387-II Study

Blood, 2015-12, Vol.126 (23), p.1600-1600

2015

Volltextzugriff (PDF)

Spatially Adaptive Bayesian Penalized Splines With Heteroscedastic Errors

Journal of computational and graphical statistics, 2007-06, Vol.16 (2), p.265-288

2007

Volltextzugriff (PDF)

Log-Linear Models for Gene Association

Journal of the American Statistical Association, 2009-06, Vol.104 (486), p.597-607

2009

Volltextzugriff (PDF)

Bayesian model selection for high-dimensional high-throughput data

Joshi, Adarsh

2010

Volltextzugriff (PDF)

Capacity Using L-Branch Channel MRC System Over Weibull Fading Channels—A Review

Advances in Communication and Computational Technology, 2020, Vol.668, p.689-706

2020

Volltextzugriff (PDF)

Vermicompost as an effective organic fertilizer and biocontrol agent: effect on growth, yield and quality of plants

Reviews in environmental science and biotechnology, 2015-03, Vol.14 (1), p.137-159

2015

Volltextzugriff (PDF)

Gut microbiota and their putative metabolic functions in fragmented Bengal tiger population of Nepal

PloS one, 2019-08, Vol.14 (8), p.e0221868

2019

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Englisch
(98)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung

A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma

357 TAK-573, an anti-CD38–attenuated interferon alpha (IFNα) fusion protein (Attenukine™), has demonstrated IFNα receptor (IFNAR) pathway modulation in patients with relapsed/refractory multiple myeloma

Molecular analysis of circulating tumor DNA (ctDNA) in patients (pts) with EGFR exon 20 insertion-positive (ex20ins+) advanced NSCLC treated with mobocertinib

Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

Statistical design for a confirmatory trial with a continuous predictive biomarker: A case study

Modakafusp Alfa Demonstrates Type I Interferon-Mediated Innate and Adaptive Immune Enhancement in a Phase 1/2 Study in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Role of Cell Therapy Product Characteristics in Patient Response to TAK-940 (CD19(T2)28z1xx Chimeric Antigen Receptor (CAR) T): Biomarker Analyses from a Phase I Study in Adult Patients with Relapsed or Refractory B-Cell Malignancies

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL

A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer

Abstract 2781: De novo molecular mechanisms of resistance to mobocertinib

Abstract A024: Genomic peroxisome proliferator-activated receptor gamma (PPARG) study: A sponsored testing program to identify patients harboring genetic alterations in advanced UC in support of the FX-909 Phase 1 study

Abstract CT065: Modakafusp alfa shows intratumoral immune pharmacodynamics (PD) in a subset of patients (pts) in a phase 1b study in advanced/metastatic solid tumors

A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer

A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer

Safety, Pharmacokinetics and Pharmacodynamics of Selgantolimod, an Oral Toll-Like Receptor 8 Agonist: A Phase Ia Study in Healthy Subjects

A phase 2, single‐arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy

Circulating Cytokines and Markers of Iron Metabolism in Myelofibrosis Patients Treated with Momelotininb: Correlatives from the Ym-387-II Study

Spatially Adaptive Bayesian Penalized Splines With Heteroscedastic Errors

Log-Linear Models for Gene Association

Bayesian model selection for high-dimensional high-throughput data

Capacity Using L-Branch Channel MRC System Over Weibull Fading Channels—A Review

Vermicompost as an effective organic fertilizer and biocontrol agent: effect on growth, yield and quality of plants

Gut microbiota and their putative metabolic functions in fragmented Bengal tiger population of Nepal

Suchergebnisse filtern